Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-11-03

FDA Approved: GATIFLOXACIN — Original Application (Leading Pharma, LLC)

View source ↗

Summary

FDA approved gatifloxacin ophthalmic solution 0.5% under an original ANDA from Leading Pharma, LLC for use in treating bacterial conjunctivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gatifloxacin ophthalmic solution 0.5% (Gatifloxacin)

Snippet

ORIG AP for GATIFLOXACIN (GATIFLOXACIN)